Acyclovir injection
Products billed under this code include Acyclovir Sodium.
Payment limit per 5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Acyclovir Sodium.
Payment limit per 5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Acyclovir Sodium | Eugia US LLC | 55150-0154-10 | 1000 | $48.00 |
| Acyclovir Sodium | Eugia US LLC | 55150-0155-20 | 2000 | $96.00 |
| Acyclovir Sodium | FreseniUS Kabi USA, LLC | 63323-0325-10 | 1000 | $48.00 |
| Acyclovir Sodium | FreseniUS Kabi USA, LLC | 63323-0325-14 | 1000 | $48.00 |
| Acyclovir Sodium | FreseniUS Kabi USA, LLC | 63323-0325-20 | 2000 | $96.00 |
| Acyclovir Sodium | FreseniUS Kabi USA, LLC | 63323-0325-24 | 2000 | $96.00 |
| Acyclovir Sodium | FreseniUS Kabi USA, LLC | 65219-0622-10 | 1000 | $48.00 |
| Acyclovir Sodium | FreseniUS Kabi USA, LLC | 65219-0624-20 | 2000 | $96.00 |
| Acyclovir Sodium | Slate Run Pharmaceuticals | 70436-0030-82 | 1000 | $48.00 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.048 | +$0.013 | 5 MG | Acyclovir injection | v1, posted September 17, 2026 |
| 3Q26 | $0.035 | +$0.018 | 5 MG | Acyclovir injection | v1, posted September 15, 2026 |
| 2Q26 | $0.017 | −$0.102 | 5 MG | Acyclovir injection | v1, posted September 15, 2026 |
| 1Q26 | $0.119 | +$0.082 | 5 MG | Acyclovir injection | v1, posted September 15, 2026 |
| 4Q25 | $0.037 | +$0.008 | 5 MG | Acyclovir injection | v1, posted September 8, 2026 |
| 3Q25 | $0.029 | −$0.006 | 5 MG | Acyclovir injection | v1, posted March 10, 2026 |
| 2Q25 | $0.035 | −$0.016 | 5 MG | Acyclovir injection | v1, posted March 10, 2026 |
| 1Q25 | $0.051 | +$0.025 | 5 MG | Acyclovir injection | v1, posted December 19, 2025 |
| 4Q24 | $0.026 | −$0.013 | 5 MG | Acyclovir injection | v1, posted June 11, 2025 |
| 3Q24 | $0.039 | −$0.02 | 5 MG | Acyclovir injection | v1, posted June 11, 2025 |
| 2Q24 | $0.059 | +$0.003 | 5 MG | Acyclovir injection | v1, posted March 11, 2025 |
| 1Q24 | $0.056 | +$0.005 | 5 MG | Acyclovir injection | v1, posted December 19, 2024 |
| 4Q23 | $0.051 | +$0.004 | 5 MG | Acyclovir injection | v1, posted October 10, 2024 |
| 3Q23 | $0.047 | +$0.007 | 5 MG | Acyclovir injection | v1, posted June 5, 2024 |
| 2Q23 | $0.04 | −$0.01 | 5 MG | Acyclovir injection | v1, posted February 23, 2024 |
| 1Q23 | $0.05 | −$0.013 | 5 MG | Acyclovir injection | v1, posted December 6, 2023 |
| 4Q22 | $0.063 | +$0.042 | 5 MG | Acyclovir injection | v1, posted June 22, 2023 |
| 3Q22 | $0.021 | −$0.007 | 5 MG | Acyclovir injection | v1, posted June 9, 2023 |
| 2Q22 | $0.028 | −$0.013 | 5 MG | Acyclovir injection | v1, posted December 14, 2022 |
| 1Q22 | $0.041 | +$0.003 | 5 MG | Acyclovir injection | v1, posted June 8, 2022 |
| 4Q21 | $0.038 | −$0.002 | 5 MG | Acyclovir injection | v1, posted June 2, 2022 |
| 3Q21 | $0.04 | +$0.006 | 5 MG | Acyclovir injection | v1, posted June 2, 2022 |
| 2Q21 | $0.034 | −$0.008 | 5 MG | Acyclovir injection | v1, posted March 1, 2022 |
| 1Q21 | $0.042 | – | 5 MG | Acyclovir injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.